Drug Improves Survival for Rare, Deadly Kidney Cancer

MONDAY, Feb. 22, 2021 — The drug cabozantinib is more effective than two similar drugs, as well as the current standard treatment, in extending the lives of patients with a rare and deadly type of kidney cancer, according to a new study.
The cancer…
Source: Topamax